121 related articles for article (PubMed ID: 16408702)
1. [TNF blockade in rheumatoid arthritis can cause severe fibrosing alveolitis. Six case reports].
Tengstrand B; Ernestam S; Engvall IL; Rydvald Y; Hafström I
Lakartidningen; 2005 Dec 5-11; 102(49):3788-90, 3793. PubMed ID: 16408702
[TBL] [Abstract][Full Text] [Related]
2. [Clinical experience with TNF-alpha inhibitors in rheumatoid arthritis].
Wallenius M; Rødevand E; Skomsvoll JF
Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1664-6. PubMed ID: 15976836
[TBL] [Abstract][Full Text] [Related]
3. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers.
Seong SS; Choi CB; Woo JH; Bae KW; Joung CL; Uhm WS; Kim TH; Jun JB; Yoo DH; Lee JT; Bae SC
J Rheumatol; 2007 Apr; 34(4):706-11. PubMed ID: 17309133
[TBL] [Abstract][Full Text] [Related]
4. [Increased risk of infection with biological immunomodifying antirheumatic agents. Clear guidelines are necessary as shown by case reports].
Söderlin M; Blomkvist C; Dahl P; Forsberg P; Fohlman J
Lakartidningen; 2005 Dec 5-11; 102(49):3794-6, 3799-800. PubMed ID: 16408703
[TBL] [Abstract][Full Text] [Related]
5. [Serious lung disease in RA and TNF-blockade--is there a connection?].
Turesson C; Jacobsson L; Saxne T; Geborek P
Lakartidningen; 2006 Feb 1-7; 103(5):308; author reply 308-9. PubMed ID: 16512575
[No Abstract] [Full Text] [Related]
6. Survival and safety of treatment with infliximab in the elderly population.
Chevillotte-Maillard H; Ornetti P; Mistrih R; Sidot C; Dupuis J; Dellas JA; Tavernier C; Maillefert JF
Rheumatology (Oxford); 2005 May; 44(5):695-6. PubMed ID: 15705631
[No Abstract] [Full Text] [Related]
7. Anti-TNF-alpha-induced systemic lupus syndrome.
Debandt M; Vittecoq O; Descamps V; Le Loët X; Meyer O
Clin Rheumatol; 2003 Feb; 22(1):56-61. PubMed ID: 12605321
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis and anti-TNF-alpha treatment.
Ormerod LP
Thorax; 2004 Nov; 59(11):921. PubMed ID: 15516463
[No Abstract] [Full Text] [Related]
10. Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas.
Geborek P; Bladström A; Turesson C; Gulfe A; Petersson IF; Saxne T; Olsson H; Jacobsson LT
Ann Rheum Dis; 2005 May; 64(5):699-703. PubMed ID: 15695534
[TBL] [Abstract][Full Text] [Related]
11. Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden.
Askling J; Fored CM; Brandt L; Baecklund E; Bertilsson L; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Romanus V; Klareskog L; Feltelius N
Arthritis Rheum; 2005 Jul; 52(7):1986-92. PubMed ID: 15986370
[TBL] [Abstract][Full Text] [Related]
12. Perforating folliculitis associated with tumour necrosis factor-alpha inhibitors administered for rheumatoid arthritis.
Gilaberte Y; Coscojuela C; Vázquez C; Roselló R; Vera J
Br J Dermatol; 2007 Feb; 156(2):368-71. PubMed ID: 17223880
[TBL] [Abstract][Full Text] [Related]
13. [Unnecessary to scare the patients].
Hansen B; Book C
Lakartidningen; 2006 Jan 11-17; 103(1-2):63. PubMed ID: 16465854
[No Abstract] [Full Text] [Related]
14. Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients.
Gerloni V; Pontikaki I; Gattinara M; Fantini F
Ann Rheum Dis; 2008 Aug; 67(8):1145-52. PubMed ID: 17981916
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.
Mäki-Petäjä KM; Hall FC; Booth AD; Wallace SM; Yasmin ; Bearcroft PW; Harish S; Furlong A; McEniery CM; Brown J; Wilkinson IB
Circulation; 2006 Sep; 114(11):1185-92. PubMed ID: 16952987
[TBL] [Abstract][Full Text] [Related]
16. Use of tumor necrosis factor-alpha inhibitors in patients with chronic hepatitis B infection.
Carroll MB; Bond MI
Semin Arthritis Rheum; 2008 Dec; 38(3):208-17. PubMed ID: 18221983
[TBL] [Abstract][Full Text] [Related]
17. Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab.
Ostor AJ; Crisp AJ; Somerville MF; Scott DG
BMJ; 2004 Nov; 329(7477):1266. PubMed ID: 15564258
[No Abstract] [Full Text] [Related]
18. Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis.
Hagiwara K; Sato T; Takagi-Kobayashi S; Hasegawa S; Shigihara N; Akiyama O
J Rheumatol; 2007 May; 34(5):1151-4. PubMed ID: 17444583
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis.
Ostör AJ; Chilvers ER; Somerville MF; Lim AY; Lane SE; Crisp AJ; Scott DG
J Rheumatol; 2006 Mar; 33(3):622-8. PubMed ID: 16511933
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine modulation induced by selective blockade of TNF-alpha in rheumatoid arthritis.
di Comite G; Marinosci A; Di Matteo P; Manfredi A; Rovere-Querini P; Baldissera E; Aiello P; Corti A; Sabbadini MG
Ann N Y Acad Sci; 2006 Jun; 1069():428-37. PubMed ID: 16855170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
